Requesting an assessment of the social and financial effects of mandating health insurance coverage for intravenous ketamine therapy to treat.

The Hawaii Legislature proposes to require insurance coverage for intravenous ketamine therapy to treat depression. Before this mandate can be considered, the Auditor must assess both the social and financial effects of the proposed coverage. The Auditor will submit a report to the Legislature no later than twenty days before the convening of the Regular Session of 2027.

Requesting an assessment of the social and financial effects of mandating health insurance coverage for intravenous ketamine therapy to treat.

The Hawaii Legislature proposes to require insurance coverage for intravenous ketamine therapy to treat depression. Before this mandate can be considered, the Auditor must assess both the social and financial effects of the proposed coverage. The Auditor will submit a report to the Legislature no later than twenty days before the convening of the Regular Session of 2027.